Mark Egerton
Chief Executive Officer at Quotient Sciences (Reading) Ltd.
Profile
Mark Egerton currently works at Quotient Sciences (Reading) Ltd., as Chief Executive Officer & Director from 2005, Watch Bidco Ltd., as Director, Watch Midco 1 Ltd., as Director, Quotient Sciences Holdings Ltd., as Director from 2016, Quad UK Topco Ltd., as Director from 2019, and Quad UK Bidco Ltd., as Director.
Dr. Egerton also formerly worked at Pharmaceutical Profiles Group Ltd., as Chief Executive Officer, Quotient Sciences Ltd., as Chief Executive Officer from 2005 to 2014, Ascot Midco 2 Ltd., as Director, Incyte Pharmaceuticals, Inc., as Vice President-European Business Operations, Oxagen Ltd., as Chief Business Officer, Sandoz Ltd., as Research Scientist, and Zeneca Pharmaceuticals, as Research Leader.
Dr. Egerton received his doctorate degree from The University of Edinburgh.
Mark Egerton active positions
| Companies | Position | Start |
|---|---|---|
Watch Bidco Ltd.
 Watch Bidco Ltd. Financial ConglomeratesFinance Watch Bidco Ltd. functions as an investment holding British company. The private company is based in Ruddington, UK. | Director/Board Member | - |
Watch Midco 1 Ltd.
 Watch Midco 1 Ltd. Financial ConglomeratesFinance Part of Watch Topco Ltd., Watch Midco 1 Ltd. functions as an investment holding British company. The company is based in Ruddington, UK and was founded in 2015. | Director/Board Member | 2016-01-19 |
Quotient Sciences Holdings Ltd.
 Quotient Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Watch Topco Ltd., Quotient Sciences Holdings Ltd. is an investment holding British company. The company is based in Nottingham, UK. Quotient Sciences Holdings was founded in 2015. | Director/Board Member | 2016-01-19 |
Quotient Sciences (Reading) Ltd.
 Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Chief Executive Officer | 2005-07-31 |
Quad UK Topco Ltd.
 Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2019, Quad UK Topco Ltd. is a holding company that oversees subsidiaries engaged in pharmaceutical research, development, and manufacturing. The company is based in Ruddington, UK. | Director/Board Member | 2019-09-30 |
Quad UK Bidco Ltd.
 Quad UK Bidco Ltd. Financial ConglomeratesFinance Part of Quad UK Midco 2 Ltd., Quad UK Bidco Ltd. functions as an investment holding company. The company is based in Ruddington, UK. | Director/Board Member | - |
Former positions of Mark Egerton
| Companies | Position | End |
|---|---|---|
Quotient Sciences Ltd.
 Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom. | Chief Executive Officer | 2023-10-15 |
Ascot Midco 2 Ltd.
 Ascot Midco 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Ascot Midco 2 Ltd. engages in the research and experimental development on biotechnology. The company is headquartered in Birmingham, the United Kingdom. | Director/Board Member | - |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Mark Egerton
| The University of Edinburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Incyte Pharmaceuticals, Inc.
 Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Health Technology |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Pharmaceutical Profiles Group Ltd.
 Pharmaceutical Profiles Group Ltd. Pharmaceuticals: MajorHealth Technology Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK. | Health Technology |
Sandoz Ltd.
 Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Health Technology |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Health Technology |
Ascot Midco 2 Ltd.
Ascot Midco 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Ascot Midco 2 Ltd. engages in the research and experimental development on biotechnology. The company is headquartered in Birmingham, the United Kingdom. | Commercial Services |
Watch Bidco Ltd.
Watch Bidco Ltd. Financial ConglomeratesFinance Watch Bidco Ltd. functions as an investment holding British company. The private company is based in Ruddington, UK. | Finance |
Quotient Sciences (Reading) Ltd.
Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Health Technology |
Watch Midco 1 Ltd.
Watch Midco 1 Ltd. Financial ConglomeratesFinance Part of Watch Topco Ltd., Watch Midco 1 Ltd. functions as an investment holding British company. The company is based in Ruddington, UK and was founded in 2015. | Finance |
Quotient Sciences Holdings Ltd.
Quotient Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Watch Topco Ltd., Quotient Sciences Holdings Ltd. is an investment holding British company. The company is based in Nottingham, UK. Quotient Sciences Holdings was founded in 2015. | Finance |
Quad UK Topco Ltd.
Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2019, Quad UK Topco Ltd. is a holding company that oversees subsidiaries engaged in pharmaceutical research, development, and manufacturing. The company is based in Ruddington, UK. | Health Technology |
Quad UK Bidco Ltd.
Quad UK Bidco Ltd. Financial ConglomeratesFinance Part of Quad UK Midco 2 Ltd., Quad UK Bidco Ltd. functions as an investment holding company. The company is based in Ruddington, UK. | Finance |
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mark Egerton
